BARASCH RICHARD A
BARASCH RICHARD A's purchase track record
BARASCH RICHARD A has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/26/2025 | STLN | $1.42M | pending | pending | — |
| 3/17/2023 | STLN | $27K | pending | pending | — |
| 11/24/2021 | STLN | $35K | pending | pending | — |
| 11/16/2021 | STLN | $42K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
AdaptHealth (AHCO) flagged in Yahoo's cautionary stock list. A recent Yahoo article placed AHCO among three stocks that Wall Street should think twice about. The piece suggests investors may need to re‑evaluate expectations for the company. The stock is currently near its long‑term support level of $5.70 and shows a moderate RSI, which aligns with the cautious tone of the article.
Transaction History
| STLN | ▼ Sell | Other | 287,756 | $0 | 7/24/2025 | View on chart |
| STLN | ▼ Sell | Other | 620,400 | $0 | 6/18/2025 | View on chart |
| STLN | ▼ Sell | Other | 159,500 | $0 | 6/17/2025 | View on chart |
| STLN | ▼ Sell | Other | 679,224 | $814K | 6/17/2025 | View on chart |
| STLN | ▼ Sell | Tax Withholding | 311,128 | $814K | 6/17/2025 | View on chart |
| STLN | ▲ Buy | Open Market | 1,358,448 | $1.4M | 3/26/2025 | View on chart |
| STLN | ▲ Buy | Grant | 80,000 | $0 | 11/22/2024 | View on chart |
| AHCO | ▼ Sell | Tax Withholding | 3,559 | $35K | 6/18/2024 | View on chart |
| AHCO | ▼ Sell | Tax Withholding | 8,547 | $84K | 5/7/2024 | View on chart |
| AHCO | ▲ Buy | Grant | 8,829 | $0 | 4/30/2024 | View on chart |
| AHCO | ▲ Buy | Grant | 21,206 | $0 | 3/2/2024 | View on chart |
| AHCO | ▼ Sell | Tax Withholding | 8,984 | $92K | 2/29/2024 | View on chart |
| AHCO | ▼ Sell | Tax Withholding | 9,226 | $67K | 1/2/2024 | View on chart |
| AHCO | ▲ Buy | Grant | 22,291 | $0 | 12/29/2023 | View on chart |
| STLN | ▲ Buy | Grant | 80,000 | $0 | 12/26/2023 | View on chart |
| AHCO | ▲ Buy | Grant | 22,891 | $0 | 10/31/2023 | View on chart |
| AHCO | ▼ Sell | Tax Withholding | 6,908 | $82K | 8/31/2023 | View on chart |
| AHCO | ▲ Buy | Grant | 13,698 | $0 | 8/31/2023 | View on chart |
| AHCO | ▲ Buy | Grant | 17,143 | $0 | 6/26/2023 | View on chart |
| AHCO | ▲ Buy | Grant | 25,614 | $0 | 6/22/2023 | View on chart |
| STLN | ▲ Buy | Open Market | 2,146 | $1K | 3/17/2023 | View on chart |
| STLN | ▲ Buy | Open Market | 10,000 | $6K | 3/17/2023 | View on chart |
| STLN | ▲ Buy | Open Market | 10,000 | $6K | 3/17/2023 | View on chart |
| STLN | ▲ Buy | Open Market | 10,000 | $6K | 3/17/2023 | View on chart |
| STLN | ▲ Buy | Open Market | 52 | $29 | 3/17/2023 | View on chart |
| STLN | ▲ Buy | Open Market | 200 | $110 | 3/17/2023 | View on chart |
| STLN | ▲ Buy | Open Market | 9,948 | $5K | 3/17/2023 | View on chart |
| STLN | ▲ Buy | Open Market | 7,654 | $4K | 3/17/2023 | View on chart |
| STLN | ▲ Buy | Grant | 22,708 | $0 | 11/17/2022 | View on chart |
| STLN | ▼ Sell | Other | 8 | $0 | 10/5/2022 | View on chart |
| STLN | ▼ Sell | Other | 1 | $0 | 10/5/2022 | View on chart |
| AHCO | ▲ Buy | Grant | 14,970 | $0 | 6/22/2022 | View on chart |
| STLN | ▲ Buy | Grant | 45,905 | $0 | 3/21/2022 | View on chart |
| STLN | ▲ Buy | Open Market | 2,000 | $14K | 11/24/2021 | View on chart |
| STLN | ▲ Buy | Open Market | 1,200 | $9K | 11/24/2021 | View on chart |
| STLN | ▲ Buy | Open Market | 1,800 | $12K | 11/24/2021 | View on chart |
| STLN | ▲ Buy | Open Market | 500 | $3K | 11/23/2021 | View on chart |
| STLN | ▲ Buy | Open Market | 4,500 | $29K | 11/23/2021 | View on chart |
| STLN | ▲ Buy | Open Market | 1,000 | $10K | 11/16/2021 | View on chart |
| STLN | ▼ Sell | Other | 14,887 | — | 11/12/2021 | View on chart |
| STLN | ▼ Sell | Other | 100,000 | — | 11/12/2021 | View on chart |
| AHCO | ▲ Buy | Grant | 9,017 | $0 | 8/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Starling Oncology reports stronger cash flow and gross profit
Starling Oncology disclosed higher cash flow and gross profit in its latest results. The improvement has prompted analysts to consider a re‑rating of the stock. The company’s financial metrics are now better positioned relative to its recent price range.
Starling Oncology reports stronger cash flow and gross profit. Starling Oncology disclosed higher cash flow and gross profit in its latest results. The improvement has prompted analysts to consider a re‑rating of the stock. The company’s financial metrics are now better positioned relative to its recent price range.